$34.08
-0.37-1.07%
Last update: Nov 5, 9:27 AM
SpyGlass Pharma Inc
SGPNASDAQ
The average analyst price target for SpyGlass Pharma is $44, 30.1% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $37 to $62. The latest change came on Aug 14, 2026, when Raymond James initiated coverage of SpyGlass Pharma with an Outperform rating and a $39 price target.
Price Target Range — 3 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
